Larimar Therapeutics, Inc. (LRMR) Form 10-K Annual Reports
Larimar Therapeutics, Inc. (LRMR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LRMR
CIK: 1374690
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerAlexander Raymond
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-01 | 2026-09-29 | 4 | 0001193125-26-410719 | View SEC Doc Filr Page |
| 3 | 2026-10-01 | 2026-09-29 | 3 | 0001193125-26-410715 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-29 | 8-K | 0001193125-26-407331 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001193125-26-331529 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-331516 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 | 0001193125-26-298523 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-29 | 8-K | 0001193125-26-286780 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-19 | 4 Filing | 0001193805-26-000669 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-19 | 4 | 0001193125-26-232933 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-19 | 4 | 0001193125-26-232705 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-19 | 4 | 0001193125-26-232667 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-19 | 4 | 0001193125-26-232657 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-19 | 4 | 0001193125-26-232644 | View SEC Doc Filr Page |
| 8-K | 2026-05-19 | 2026-05-19 | 8-K | 0001193125-26-230852 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001140361-26-021322 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001193125-26-224087 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001193125-26-222746 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-30 | — | SCHEDULE 13G/A Filing | 0001104659-26-053218 | View SEC Doc Filr Page |
| ARS | 2026-04-20 | 2025-12-31 | ARS | 0001193125-26-163954 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-20 | 2026-04-17 | DEF 14A | 0001193125-26-163942 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-10 | 2026-05-19 | PRE 14A | 0001193125-26-151258 | View SEC Doc Filr Page |
| S-8 | 2026-03-19 | — | S-8 | 0001193125-26-116159 | View SEC Doc Filr Page |
| 10-K | 2026-03-19 | 2025-12-31 | 10-K | 0001193125-26-115878 | View SEC Doc Filr Page |
| 8-K | 2026-03-19 | 2026-03-19 | 8-K | 0001193125-26-115119 | View SEC Doc Filr Page |
| 8-K | 2026-03-09 | 2026-03-09 | 8-K | 0001193125-26-098493 | View SEC Doc Filr Page |